Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Advances in immune checkpoint-based immunotherapies for multiple sclerosis: rationale and practice ; volume:21 ; number:1 ; day:9 ; month:11 ; year:2023 ; pages:1-21 ; date:12.2023
Cell communication and signaling ; 21, Heft 1 (9.11.2023), 1-21, 12.2023
- Urheber
-
Daei Sorkhabi, Amin
Komijani, Erfan
Sarkesh, Aila
Ghaderi Shadbad, Pedram
Aghebati-Maleki, Ali
Aghebati-Maleki, Leili
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12964-023-01289-9
- URN
-
urn:nbn:de:101:1-2024012911193945531423
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Daei Sorkhabi, Amin
- Komijani, Erfan
- Sarkesh, Aila
- Ghaderi Shadbad, Pedram
- Aghebati-Maleki, Ali
- Aghebati-Maleki, Leili
- SpringerLink (Online service)
Ähnliche Objekte (12)
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
Current status of chimeric antigen receptor engineered T cell-based and immune checkpoint blockade-based cancer immunotherapies
Advances in Prostate Cancer Immunotherapies
Tumor immunotherapies by immune checkpoint inhibitors (ICIs); the pros and cons
Immune biological rationales for the design of combined radio- and immunotherapies
Recent advances in immunotherapies: from infection and autoimmunity, to cancer, and back again
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Recent advances in amyotrophic lateral sclerosis
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Implantable Biomaterials for Cancer Immunotherapies
Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model